Last updated: March 21, 2023
Sponsor: National Cheng Kung University
Overall Status: Active - Recruiting
Phase
N/A
Condition
Asperger's Disorder
Autism
Autism Spectrum Disorder (Asd)
Treatment
N/AClinical Study ID
NCT05131347
A-BR-109-011
Ages 4-5 All Genders
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
- diagnosed with ASD by registered pediatric psychiatrists according to the Diagnosticand Statistical Manual-5th Edition
- aged 48 to 71 months old
- had no sensory impairments, such as visual or hearing impairments
Exclusion
Exclusion Criteria:
- diagnosed with additional diseases, comorbidities, or presence of other disorders,such as epilepsy, attention deficit hyperactivity disorder (ADHD), or Fragile Xsyndrome
- children with physical disabilities caused by head injuries, or neurological disorders
- the inability to follow researcher's instructions and complete the research procedures
Study Design
Total Participants: 30
Study Start date:
May 06, 2022
Estimated Completion Date:
December 31, 2024
Study Description
Connect with a study center
National Cheng Kung University
Tainan, 701
TaiwanActive - Recruiting
Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.